medigraphic.com
Academia Mexicana de Neurología, A.C.

2006, Number 3

<< Back Next >>

Rev Mex Neuroci 2006; 7 (3)

Current events on transient ischemic attacks III. Diagnosis and treatment

Fernández CO

Language: Spanish
References: 41
Page: 212-217
PDF size: 72.00 Kb.


ABSTRACT

Transient ischemic attacks (TIA) are episodic and focal disturbances of the cerebral and retinal circulation. It is very important the early identification, as well as the etiological evaluation and the adequate therapeutics in patients who suffer this illness, for only this way they will be able to prevent an ictus occurrence. It is in the primary attention of this illness where the therapeutical deficiencies generally appear, due to the unawareness the population has about the TIA. Since they are short-lasting periods, the clinician is not usually present when the symptom frame appears and a checkup should be made at the starting point of the observation; this is quite normal, that is why the clinical diagnosis depends exclusively on the questioning. In the end, neuroimages will be determinant to make it a difference between these and other processes capable of make believe it; the neurosonological studies will help us define a probable atheromatosis. Therapeutics must depend on the etiology and other conditions such as risk factor control, antiplateletaries, endarterectomy and anticoagulation.


REFERENCES

  1. Sherman DG. Reconsideration of TIA diagnostic criteria. Neurology 2004; 62: S20-S21.

  2. Dyken ML, Conneally M, Haerer AF, Gotshall RA, Calanchini PR, Poskanzer DC, Price TR, Swanson PD. Cooperative study of hospital frequency and character of transient ischemic attacks I. Background, organization, and clinical survey. JAMA 1977; 237(9): 882-6.

  3. Andre C, Vincent MB. On the pathogenesis of headache following TIA. Arq Neuropsiquiatr 1997; 55(2): 167-73.

  4. Larsen BH, Sorensen PS, Marquardsen J. Transient ischaemic attacks in young patients: a thromboembolic or migrainous manifestation? A 10 year follow up study of 46 patients. J Neurol Neurosurg Psychiatry 1990; 53(12): 1029-33.

  5. Dennis M, Warlow C. Migraine aura without headache: transient ischaemic attack or not? J Neurol Neurosurg Psychiatry 1992; 55(6): 437-40.

  6. Fisch BJ, Tatemichi TK, Prohovnik I. Transient ischemic attacks resembling simple partial motor seizures. Neurology 1988; 38(S1): 264.

  7. Yanagihara T, Piepgras DG, Klass DW. Repetitive involuntary movement associated with episodic cerebral ischaemia. Ann Neurol 1985; 18: 244-50.

  8. Baquis GD, Pessin MS, Scott RM. Limb shaking-a carotid TIA. Stroke 1985; 16: 444-8.

  9. Tatemichi TK, Young WL, Prohovnik I. Perfusion insufficiency in limb-shaking transient ischemic attacks. Stroke 1990; 21: 341-7.

  10. Baumgartner RW, Baumgartner I. Vasomotor reactivity is exhausted in transient ischaemic attacks with limb shaking. J Neurol Neurosurg Psychiatry 1998; 65: 561-4.

  11. Niehaus L, Neuhauser H, Meyer BU. TIAs of hemodynamic origin mimicking simple partial motor seizures. Nervenarzt 1998; 69: 901-4.

  12. Klijn CJM, Kappelle LJ, van Huffelen AC, et al. Recurrent ischemia in symptomatic carotid occlusion. Prognostic value of hemodynamic factors. Neurology 2000; 55: 1806-12.

  13. Firlik AD, Firlik KS, Yonas H. Physiological diagnosis and surgical treatment of recurrent limb shaking: case report. Neurosurgery 1996; 39: 607-11.

  14. Kim JW, Choi SH, Kim WJ, Chun SM. Transient ischemic attacks presenting as hemiballism. Mov Disord 2003; 18(11): 1399-401.

  15. Delgado-Acosta F, Bravo-Rodriguez F, Ochoa-Sepulveda JJ, Bautista-Rodriguez MD. Ataque isquémico cerebral como única manifestación de una fistula arteriovenosa dural. Rev Neurol 2003; 37(10): 931-4.

  16. Gilhuis HJ, Kappelle AC, Swen JW, Vecht ChJ. Not every TIA is primarily vascular. Ned Tijdschr Geneeskd. 2003; 147(37): 1769-72.

  17. García Pastor A, Iniesta López I, de Andrés C. Tumores intracraneales que se manifiestan simulando ataques isquémicos transitorios. Rev Neurol 2001; 33(9): 839-42.

  18. Tushla MC, Waltke EA, Aita JF. Transient ischemic attack (TIA) secondary to subdural hematoma. Nebr Med J 1992; 77(10): 273-6.

  19. Ferro JM, Falcao I, Rodrigues G, Canhao P, Melo TP, Oliveira V, et al. Diagnosis of transient ischemic attack by the nonneurologist. A validation study. Stroke 1996; 27(12): 2225-9.

  20. Davidson E, Rotenbeg Z, Fuchs J, Weinberger I, Agmon J. Transient ischemic attack-related syncope. Clin Cardiol 1991; 14(2): 141-4.

  21. Nguyen-Huynh MN, Fayad P, Gorelick PB, Johnston SC. Knowledge and management of transient ischemic attacks among US primary care physicians. Neurology 2003; 61: 1455-6.

  22. Goldstein LB, Bian J, Samsa GP. New transient ischemic attack and stroke. Outpatient management by primary care physicians. Arch Intern Med 2000; 160: 2941-6.

  23. Albers GW, Yim JM, Belew KM. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Arch Intern Med 1996; 156: 2311-6.

  24. Benade MM, Warlow CP. Cost of identifying patients for carotid endarterectomy. Stroke 2002; 33: 435-9.

  25. Johnston SC. Transient Ischemic Attack. N Engl J Med 2002; 347(21): 1687-92.

  26. Aburahma AF, Thiele SP, Wulu JT Jr. Prospective controlled study of the natural history of asymptomatic 60% to 69% carotid stenosis according to ultrasonic plaque morphology. J Vasc Surg 2002; 36(3): 437-42.

  27. Rappeport Y, Simonsen L, Christensen H, Boysen G. Prevalence of significant carotid artery stenosis in patients with transient ischaemic attack. Med Sci Monit 2002; 8(5): CR317-20.

  28. Mayor I, Comelli M, Vassileva E, Burkhard P, Sztajzel R. Microembolic signals and carotid plaque morphology: a study of 71 patients with moderate or high grade carotid stenosis. Acta Neurol Scand 2003; 108(2): 114-7.

  29. Jiang Y, Hu J, Gao Q. An analysis on the diagnostic values of transcranial Doppler and angiography in transient ischemic attack. J Tongji Med Univ 2001; 21(2): 100-1.

  30. O’Rourke F, Dean N, Akhtar N, Shuaib A. Current and future concepts in stroke prevention. CMAJ 2004; 170(7): 1123-33.

  31. Albers GW, Hart RG, Lutsep HL. AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: a statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association. Stroke 1999; 30: 2502-11.

  32. Barnett HJ, Taylor DW, Eliasziw M. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415-25.

  33. Serafini O, Misuraca G, Greco F, Bisignani G, Manes MT, Venneri N. Prevalence of structural abnormalities of the atrial septum and their association with recent ischemic stroke or transient ischemic attack: echocardiographic evaluation in 18631 patients. Ital Heart J 2003; 4 (Suppl. 1): S39-S45.

  34. Stoddard MF, Singh P, Dawn B, Longaker RA. Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J 2003; 145(4): 676-82.

  35. Hart RG, Pearce LA, Koudstaal PJ. Transient Ischemic Attacks in Patients With Atrial Fibrillation. Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial. Stroke 2004; 35: 948.

  36. Yahia AM, Kirmani JF, Xavier AR, Shaukat A, Qureshi AI. Characteristics and predictors of aortic plaques in patients with transient ischemic attacks and strokes. J Neuroimaging 2004; 14(1): 16-22.

  37. van Goor MPJ, Alblas CL, Leebeek FWG, PJ Koudstaal, Dippel DWJ. Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke? Acta Neurol Scand 2004; 109(6): 410-4.

  38. Janardhan V, Wolf PA, Kase CS, Massaro JM, D’Agostino RB, Franzblau, et al. Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study. Stroke 2004; 35(3): 736-41.

  39. Amarenco P, Lavallée P, Touboul PJ. Stroke prevention, blood cholesterol, and statins. Lancet Neurol 2004; 3: 271-8.

  40. Manktelow B, Gillies C, Potter JF. Interventions in the management of serum lipids for preventing stroke recurrence. Cochrane Database Syst Rev 2002; 3: CD002091.

  41. The SPARCL Investigators. Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL). Cerebrovasc Dis 2003; 16: 389-95.




2020     |     www.medigraphic.com